# Anemia in inflammatory bowel disease course is associated with patients' worse outcome
ğŸ“Š *Analyzing the impact of anemia on inflammatory bowel disease (IBD) patient outcomes using advanced statistical methods*  

## ğŸš€ Project Overview  
Anemia significantly affects the **quality of life and clinical outcomes** in patients with **inflammatory bowel disease (IBD)**. However, there has been **limited research in Asian populations**.  

ğŸ“ **Objective:** Investigate the **prevalence, risk factors, and impact of anemia** in IBD patients in Taiwan.  
ğŸ¥ **Data Source:** 1604 IBD patients from **National Taiwan University Hospital** (2006â€“2018).  
ğŸ“ˆ **Key Insight:** **Persistent anemia leads to worse outcomes, including higher hospitalization and mortality rates**.  

---

## ğŸ” Key Findings  
ğŸ“¢ **Anemia screening improved over time**  
âœ… 62.6% of IBD patients were screened in **2006** â†’ **77.2%** by **2017**  
âœ… Mean time to anemia screening:  
   - **Crohnâ€™s Disease (CD):** 122.4 days  
   - **Ulcerative Colitis (UC):** 216.2 days  

ğŸ“¢ **Persistent anemia is a major concern**  
ğŸ©¸ **47.3%** of screened IBD patients had persistent anemia  

ğŸ“¢ **Major risk factors for persistent anemia**  
ğŸ”¹ **Low BMI** (**OR = 1.96, p < 0.01**)  
ğŸ”¹ **Steroid use** (**OR = 2.96, p < 0.01**)  
ğŸ”¹ **Thiopurine therapy** (**OR = 2.62, p < 0.01**)  
ğŸ”¹ **Colectomy** (**OR = 6.3, p < 0.01**)  
ğŸ”¹ **Small bowel resection** (**OR = 3.21, p < 0.05**)  

ğŸ“¢ **Clinical Impact**  
âš ï¸ **Anemic IBD patients had significantly higher**:  
- **Hospital admission rates** (**p < 0.01**)  
- **Mortality rates** (**p < 0.01**)  

ğŸ“¢ **Recommendation**  
âœ… **Early anemia screening & treatment** should be prioritized in IBD management  

---

## ğŸ› ï¸ Skills & Tools Used  
ğŸ“Š **Statistical Methods:** Logistic Regression, Odds Ratio Calculation, Trend Analysis  
ğŸ“‰ **Programming:** SAS (`PROC LOGISTIC`, `PROC FREQ`)  
ğŸ—‚ **Data Handling:** Retrospective Cohort Analysis  
ğŸ¤ **Collaboration:** Worked closely with **doctors, researchers, and clinicians** to analyze data and derive actionable insights  

---

## ğŸ“„ Publication  
ğŸ“Œ This study was published in **Journal of the Formosan Medical Association**.  
ğŸ”— **DOI:** https://doi.org/10.1016/j.jfma.2022.11.004

---

## ğŸ’¡ Why This Matters  
ğŸ¯ This research demonstrates my ability to:  
âœ”ï¸ **Analyze large-scale hospital data** to uncover critical clinical trends  
âœ”ï¸ **Apply statistical techniques** to solve real-world healthcare challenges  
âœ”ï¸ **Collaborate with multidisciplinary teams**, bridging the gap between data science and medicine  
âœ”ï¸ **Publish impactful research** that influences clinical decision-making  

---

## ğŸ“¬ More Information  
ğŸ“© Feel free to reach out via **[LinkedIn/email]** for more details!  
